Skip to main content

Table 2 Percent improvement of secondary rating scale scores

From: The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial

 

Q+CBT

(N = 11)

P+CBT

(N = 11)

Between group

differences

HADS

20%a

6%

ns

CGI-S

33%c

12%a

ns

CGI-I

33%c

23%a

ns

Q-LES-Q

29%b

2%

p < 0.05d

  1. a p < 0.05, t-test for paired values comparing screen (or randomization) and LOCF scores for individual rating scales within each group.
  2. b p < 0.01, t-test for paired values comparing screen and LOCF scores for the Q-LES-Q rating scale within each group.
  3. c p < 0.005, t-test for paired values comparing screen (or randomization) and LOCF scores for individual rating scales within each group.
  4. d ANCOVA using screen scores as covariates and LOCF scores as outcome.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us